Faeth Therapeutics Appoints Debbie Chirnomas, M.D., M.P.H., As Chief Medical Officer Benzinga

Sep 29, 2023•about 2 years ago

Position

Chief Medical Officer

Company

Faeth Therapeutics

Debbie Chirnomas

San Francisco

Description

Faeth Therapeutics , a clinical-stage biotechnology company targeting cancer metabolism, today announced the appointment of Debbie Chirnomas M.D., M.P.H., as Chief Medical Officer. Dr. Chirnomas will head up the early and late-stage clinical development for Faeth's oncology pipeline.

Company Information

Company

Faeth Therapeutics

Location

San Francisco, California, United States

About

Everything needs food to survive and grow, including cancer. There is an entire dimension of human biology in metabolism that’s been too complex to leverage in the fight against cancer––until now.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Faeth Therapeutics Appoints Debbie Chirnomas, M.D., M.P.H., As Chief Medical Officer Benzinga

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information